Literature DB >> 12202666

Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer.

Patricia J Eifel1, Anuja Jhingran, Diane C Bodurka, Charles Levenback, Howard Thames.   

Abstract

PURPOSE: The purpose of this study was to identify patient-related factors that influence the risk of serious late complications of pelvic radiation therapy. PATIENTS AND METHODS: The records of 3,489 patients treated with radiation therapy for International Federation of Gynecology and Obstetrics stage I or II carcinoma of the cervix were reviewed for information about patient characteristics, treatment details, and outcomes. Any complication occurring or persisting more than 3 months after treatment that required hospitalization, transfusion, or an operation or caused severe symptoms or the patient's death was considered a major late complication. Complication rates were calculated actuarially. The median duration of follow-up was 85 months, and 99% of patients were followed for at least 3 years or until they died.
RESULTS: Heavy smoking was the strongest independent predictor of overall complications (multivariate hazard ratio, 2.30; 95% confidence interval [CI], 1.84 to 2.87). The most striking influence of smoking was on the incidence of small bowel complications (hazard ratio for smokers of one or more packs per day, 3.25; 95% CI, 2.21 to 4.78). Hispanics had a significantly lower rate of small bowel complications than whites, and blacks had higher rates of bladder and rectal complications than whites. Thin women had an increased risk of gastrointestinal complications, and obese women were more likely to have serious bladder complications.
CONCLUSION: Complications of pelvic radiation therapy are strongly correlated with smoking, race, and other patient characteristics. These factors should be considered before the results of clinical studies are generalized to different cultural and racial groups.

Entities:  

Mesh:

Year:  2002        PMID: 12202666     DOI: 10.1200/JCO.2002.10.128

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  39 in total

1.  Evaluating toxicity in neoadjuvant radio-chemotherapy of rectal cancer.

Authors:  Stefan Höcht
Journal:  Int J Colorectal Dis       Date:  2003-07-15       Impact factor: 2.571

Review 2.  Radiation enteropathy--pathogenesis, treatment and prevention.

Authors:  Martin Hauer-Jensen; James W Denham; H Jervoise N Andreyev
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-04-01       Impact factor: 46.802

Review 3.  Radiation dose-volume effects of the urinary bladder.

Authors:  Akila N Viswanathan; Ellen D Yorke; Lawrence B Marks; Patricia J Eifel; William U Shipley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

4.  NZO/HlLtJ as a novel model for the studies on the role of metabolic syndrome in acute radiation toxicity.

Authors:  Laura E Ewing; Isabelle R Miousse; Rupak Pathak; Charles M Skinner; Stanley Kosanke; Marjan Boerma; Martin Hauer-Jensen; Igor Koturbash
Journal:  Int J Radiat Biol       Date:  2019-01-14       Impact factor: 2.694

Review 5.  The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support.

Authors:  Graham W Warren; Samantha Sobus; Ellen R Gritz
Journal:  Lancet Oncol       Date:  2014-10-26       Impact factor: 41.316

6.  The effect of cigarette smoking on cancer treatment-related side effects.

Authors:  Luke J Peppone; Karen M Mustian; Gary R Morrow; Ann M Dozier; Deborah J Ossip; Michelle C Janelsins; Lisa K Sprod; Scott McIntosh
Journal:  Oncologist       Date:  2011-12-01

Review 7.  Exploring Issues of Comorbid Conditions in People Who Smoke.

Authors:  Alana M Rojewski; Stephen Baldassarri; Nina A Cooperman; Ellen R Gritz; Frank T Leone; Megan E Piper; Benjamin A Toll; Graham W Warren
Journal:  Nicotine Tob Res       Date:  2016-01-17       Impact factor: 4.244

8.  Lifestyle modification in cervical cancer survivors: an ongoing need.

Authors:  Matthew P Schlumbrecht; Charlotte C Sun; Marilyn S Huang; Fran Zandstra; Diane C Bodurka
Journal:  Int J Gynecol Cancer       Date:  2014-03       Impact factor: 3.437

9.  Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study.

Authors:  Francesca Martra; Charles Kunos; Heidi Gibbons; Paolo Zola; Luciano Galletto; Robert DeBernardo; Vivian von Gruenigen
Journal:  Am J Obstet Gynecol       Date:  2008-01       Impact factor: 8.661

10.  Tobacco use in the oncology setting: advancing clinical practice and research.

Authors:  Ellen R Gritz; Benjamin A Toll; Graham W Warren
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.